Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

Clinical trial NCT02422641 · RECRUITING

Trial details

NCT number: NCT02422641
Sponsor: Wake Forest University Health Sciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Leptomeningeal Disease

Start date: 2015-05-01
Primary completion: 2026-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.